Horseshoe Abscess in Conjunction with Insidious Spidermoid Anal Cancer

Authors

  • García Sánchez Morelos Adolfo Colonic and Rectal Surgeon and General Surgeon Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City
  • De La Fuente González Mireya General Surgeon, Surgical Department at “Dr. Gaudencio González Garza” General Hospital Specialized Medical Unit “La Raza”, National Medical Center, Mexican Social Security Institute, National Autonomous University of Mexico México City, México
  • Estrada Rodríguez María Isabel Podiatrist Pediatrician Department. Regional General Hospital No. 251, Metepec. Mexican Social Security Institute National Autonomous University of Mexico. México State, México
  • Juárez Moyrón Miguel Fernando General Surgeon, Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City, National Autonomous University of Mexico, México City, México
  • Jiménez Bonola Yamileth General Surgeon, Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City National Autonomous University of Mexico, México City, México
  • Mauricio Israel Flores Pazos General Surgeon, Surgical Department at “Dr. Rubén Leñero” General Hospital Secretary of Health of Mexico City National Autonomous University of Mexico, México City, México

DOI:

https://doi.org/10.14738/jbemi.95.13225

Keywords:

Cancer. Epidermoid. Anal. Neoplasms. Biopsy. Carcinoma.

Abstract

Anal squamous cell cancer is extremely rare in terms of it´s presentation, an incidence of 1-2% of all neoplasms of the digestive tract is estimated. The objective is the presentation of a case and review of the literature. Case: 44-years-old male who started 14 days earlier, with increased perianal and intergluteal volumen, with an amorphous, irregular, poorly limited, hyperthermic, hard, stony extension, vegetating large elements; surgery is performed with abscess drainage and biopsy, diagnosing squamous cell carcinoma. Discussion: the treatment is chemoradiotherapy, surgery is reserved for failure of this; in the initial stage, survival is greater than 73% at 5 years and in recurrent cases, surgical rescue is relegated with results of 48% in survival. It is concluded that it is irrefutable that any lesion of the colon, rectum and anus, tumor, irregular or abnormal tissue, be biopsied and analyzed histopathologically. In addition, there is the delay in diagnosis, which is associated with the cultural beliefs of patients or their idiosyncrasy, with a shortage of qualified personnel and infrastructure in the public health sector, which is very common in developing countries.

References

Leborgne, J. H. et al. Tratamiento del cáncer de canal anal. Descripción de técnica y resultados de tratamiento radiante con o sin quimioterapia. Estudio retrospectivo en una población no seleccionada (1988 - 2016). Rev. Méd. Urug. 2019; 4:29-51.

Handerson R. O., y cols. Carcinoma escamocelular del canal anal metastásico en un paciente con VIH tratado con quimiorradioterapia concomitante. Reporte de un caso y revisión de la literatura. Rev Colomb Gastroenterol. 2019; 34 (4): 438-444.

Manuel M. S. Historia del cáncer del recto y su tratamiento quirúrgico. Revista Mexicana de Coloproctología. 2005; 2: 60-63.

Santos T.Y., Estepa P.J.L., Feliú R.J.A., et al. Caracterización de pacientes diagnosticados de carcinoma epidermoide de canal anal. Cienfuegos, 2017-2019. Medisur. 2021; 19:83-93.

García-Sánchez M.A., et al. Anorrectal Abscess an Underestimated, Silent and Rough Disease. Integration of a New Treatment Line: “Four Phases” 15 Years of Experience. EC Gastroenterology and digestive system. 2022; 9:

Franco-Herrera, R., et al. ¿Permiten la citología, el genotipado y la anoscopia de alta resolución establecer un protocolo para la detección precoz del carcinoma epidermoide de canal anal en población de riesgo?. Rev Chil Cir. 2018; 6: 523-528.

Moureau-Zabotto L, et al. Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP). Dig Liver Dis. 2017; 49:831-840. Cancer du canal anal (mise à jour le 14/04/2020).

Misa-Jalda R. and Martínez-Láuz M. Cáncer de ano. Clin Quir Fac Med UdelaR. 2018; 2:1-5.

Golia Pernicka J. S., et al. MR staging of anal cancer: what the radiologist needs to know. Abdominal Radiology. 2019; 44: 3726-3739.

Lu Y., et al. Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China. BMC Cancer. 2020; 20; 679-686.

Martin D., et al. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG). Radiotherapy & Oncology. 2022; 167: 233-238.

Palefsky J. M., et al. Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. New England Journal of Medicine. 2022; 386: 2273-2282.

Goddard S. L., et al. Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC). Cancer Epidemiology. 2019; 58: 12-16.

Saint A, Evesque L and Francois E. Metastatic squamous cell carcinomas of the anal canal: Current management and prospects. Bulletin du Cancer. 2020; 107: 792-799.

Almaazmi H., et al. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided." Journal of Surgical Research. 2020¸247: 530-540. 194

Ouchi A., et al. Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG). Japanese Journal of Clinical Oncology. 2020; 50: 368-378.

Bian S. X., Chen D. H., and Lin E. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database. Cancer Medicine. 2021:10: 575-585.

Marabelle A., et al. Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study. The Lancet. Gastroenterology & Hepatology. 2022; 7: 446-454.

Das A., et al. Intensity modulated radiotherapy in anal canal squamous cell carcinoma: Implementation and outcomes. Journal of Cancer Research & Therapeutics. 2021; 17: 975-981.

Dell'Acqua V., et al. Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy. International Journal of Colorectal Disease. 2020; 35:

Yamada K., et al. Characteristics of anal canal cancer in Japan. Cancer Medicine. 2022; 11: 2735-2743.

Yuan Y., et al. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China. Cancer Medicine. 2022; 11: 117-127.

Kloppers J, C., et al. "Requiem for Nigro or is anal squamous carcinoma still a surgical problem: Abdominoperineal excision rather than a defunctioning stoma?." South African Journal of Surgery. 2018; 56: 24-30.

Patel S. V., et al. Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population. Diseases of the Colon & Rectum. 2020; 63: 748-757.

Hagemans J. A. W., et al. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience. Annals of Surgical Oncology. 2018; 25: 1970-1979.

Eng C., Messick C., and Glynne-Jones R. The Management and Prevention of Anal Squamous Cell Carcinoma. American Society of Clinical Oncology Educational Book. 2019; 39: 216-225.

Santorelli C., et al. Screening for Squamous Cell Anal Cancer in HIV Positive Patients: A Five-Year Experience. Journal of Investigative Surgery. 2018; 31: 378-384.

Guren M. G., et al. Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer. Clinical Colorectal Cancer. 2021; 20:

Lohynska R., et al. Improved survival in patients with FDG-PET/CT-based radiotherapy treatment planning for squamous cell anal cancer. Neoplasma. 2020; 67: 1157-1163.

Johnsson A., et al. Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results. Acta Oncologica. 2022; 62: 575-582.

Downloads

Published

2022-10-17

How to Cite

Adolfo, G. S. M., Mireya, D. L. F. G., Isabel, E. R. M., Fernando, J. M. M., Yamileth, J. B., & Pazos, M. I. F. (2022). Horseshoe Abscess in Conjunction with Insidious Spidermoid Anal Cancer. British Journal of Healthcare and Medical Research, 9(5), 189–195. https://doi.org/10.14738/jbemi.95.13225

Issue

Vol. 9 No. 5 (2022): British Journal of Healthcare and Medical Research

Section

Original Articles

License

Copyright (c) 2022 García Sánchez Morelos Adolfo, De La Fuente González Mireya, Estrada Rodríguez María Isabel, Juárez Moyrón Miguel Fernando, Jiménez Bonola Yamileth, Mauricio Israel Flores Pazos

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)